drugset / Trial / NCT03326128

High Dose Bupropion for Smoking Cessation - Pilot Study

NCT03326128

RandomizedParallel-groupSingle-blindTreatment

Summary

This study aims to investigate the benefit of administering two differing doses of Bupropion (BUP) to smokers to assist with smoking cessation.

Timeline

Start
2021-09-01
Primary completion
2023-07-01
Completion
2023-07-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 300 mg
Subject Bupropion Small molecule 450 mg

Indications